Ambuja Cements Limited (AMBUJACEM) Operating Income 2021–2026

Name: Ambuja Cements Limited (AMBUJACEM) operating income history 2021-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Ambuja Cements Limited annual operating income for fiscal 2026 was ₹30.9 billion, a decrease of 15.9% from ₹36.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

AMBUJACEM Annual Operating Income

Operating Income (annual)	2026-03-31	2025-03-31	2024-03-31	2022-12-31	2021-12-31
Operating Income (EBIT)	₹30.9B	₹36.8B	₹47.8B	₹25.9B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AMBUJACEM Quarterly Operating Income

Operating Income (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Operating Income (EBIT)	₹7.5B	₹4.1B	₹3.9B	—	₹11.9B	₹11.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Operating Income at Comparable Companies

ULTRACEMCO Operating Income — UltraTech Cement Limited
GRASIM Operating Income — Grasim Industries Limited
SHREECEM Operating Income — Shree Cement Limited
5233 Operating Income — Taiheiyo Cement Corporation
JKCEMENT Operating Income — J.K. Cement Limited
DALBHARAT Operating Income — Dalmia Bharat Limited

More AMBUJACEM metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow

All AMBUJACEM financial statements → Interactive AMBUJACEM charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.